Company Overview: TherapeuticsMD

Industry News

29 Jan

Therapeutics MD

TherapeuticsMD goal is to become the recommended women’s healthcare company by health care providers to all patients by developing into a new standard with a complete line of products under one quality brand. Key elements of the TherapeuticsMD strategy to achieve this goal are as follows: Exclusive Focus on...

Read more

10 Jun

TherapeuticsMD (TXMD) Announces Webcast for Investor Day on June 16, 2014

TherapeuticsMD, Inc. (NYSE MKT:TXMD) a women’s health care company, (“TherapeuticsMD” or the “Company”) announced today that it will webcast its upcoming Investor Day on June 16, 2014 to be held at the InterContinental Barclay New York in New York City commencing promptly at 11:30 a.m. EDT to approximately 2:30...

Read more

10 Jun

TherapeuticsMD (TXMD) Announces Webcast for Investor Day on June 16, 2014

TherapeuticsMD, Inc. (NYSE MKT:TXMD) a women’s health care company, (“TherapeuticsMD” or the “Company”) announced today that it will webcast its upcoming Investor Day on June 16, 2014 to be held at the InterContinental Barclay New York in New York City commencing promptly at 11:30 a.m. EDT to approximately 2:30...

Read more

27 May

TherapeuticsMD (TXMD) Announces 2014 Investor Day

TherapeuticsMD, Inc. (NYSE MKT: TXMD) announced today that it will host its 2014 Investor Day on Monday, June 16, 2014, beginning at 11:30 a.m. EDT at the InterContinental Barclay New York in New York City. The event will feature a panel of prominent Clinical Key Opinion Leaders, Compounding Market...

Read more

2 May

TherapeuticsMD (TXMD) to Present Design of REPLENISH Trial at International Meno

TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company (“TherapeuticsMD” or the “Company”), will detail the design of its REPLENISH Trial, a large-scale pivotal phase 3 clinical trial to evaluate TX-001HR, the first oral combination for FDA approval of 17β-estradiol and progesterone in a single capsule for the treatment...

Read more

1 May

Targeted Medical Pharma Completes Middle East Distribution Agreement

Targeted Medical Pharma (TRGM), today announced the completion of an agreement between Analytical Testing Laboratories (ATL), a Lebanon based company that specializes in drug testing services and inborn errors of metabolism, for the exclusive distribution of the company’s amino acid based products to physicians and pharmacies throughout the Middle...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address